https://wikimd.org/index.php?action=history&feed=atom&title=NV-5440 2026-04-30T04:21:35Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=NV-5440&diff=6335129&oldid=prev 2025-02-20T01:35:27Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:35, 20 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l28">Line 28:</td> <td colspan="2" class="diff-lineno">Line 28:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Enzyme inhibitors]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Enzyme inhibitors]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:NV-5440 structure.png|NV-5440</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=NV-5440&diff=5374674&oldid=prev 2024-03-08T18:24:46Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;NV-5440&#039;&#039;&#039; is a novel [[small molecule]] inhibitor that targets the [[NEDD8-activating enzyme]] (NAE). It is currently under investigation for its potential use in the treatment of various [[cancer]] types. <br /> <br /> == Mechanism of Action ==<br /> <br /> NV-5440 works by inhibiting the NEDD8-activating enzyme (NAE), a critical component of the [[NEDD8 conjugation pathway]]. This pathway is responsible for the activation of [[cullin-RING ligases]] (CRLs), which are involved in the degradation of numerous [[protein]]s that regulate cell cycle progression, [[DNA repair]], and [[signal transduction]]. By inhibiting NAE, NV-5440 disrupts the function of CRLs, leading to the accumulation of these proteins and ultimately causing cell cycle arrest and [[apoptosis]].<br /> <br /> == Clinical Trials ==<br /> <br /> NV-5440 is currently in the early stages of [[clinical trials]]. Preliminary results have shown promising anti-tumor activity in preclinical models of various cancer types, including [[non-small cell lung cancer]] (NSCLC), [[ovarian cancer]], and [[pancreatic cancer]]. Further studies are needed to confirm these findings and to determine the safety and efficacy of NV-5440 in humans.<br /> <br /> == Potential Side Effects ==<br /> <br /> As NV-5440 is still in the early stages of development, the potential side effects are not yet fully known. However, based on the mechanism of action, it is possible that side effects could include [[nausea]], [[vomiting]], [[diarrhea]], and [[fatigue]]. Patients participating in clinical trials will be closely monitored for any adverse effects.<br /> <br /> == See Also ==<br /> <br /> * [[NEDD8]]<br /> * [[Cullin-RING ligases]]<br /> * [[Apoptosis]]<br /> * [[Clinical trial]]<br /> <br /> == References ==<br /> <br /> &lt;references /&gt;<br /> <br /> [[Category:Experimental cancer drugs]]<br /> [[Category:Small molecules]]<br /> [[Category:Enzyme inhibitors]]<br /> {{pharmacology-stub}}</div>

Prab